Assay and Drug Development Technologies

Papers
(The H4-Index of Assay and Drug Development Technologies is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Microneedle Technology: An Insight into Recent Advancements and Future Trends in Drug and Vaccine Delivery26
Optimization and Development of Methotrexate- and Resveratrol-Loaded Nanoemulsion Formulation Using Box–Behnken Design for Rheumatoid Arthritis26
A New Spectral Shift-Based Method to Characterize Molecular Interactions20
Albumin-Coated Mesoporous Silica Nanoparticles of Docetaxel: Preparation, Characterization, and Pharmacokinetic Evaluation16
Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design16
Fabrication of Mupirocin-Loaded Nanostructured Lipid Carrier and Its In Vitro Characterization14
Modifications to the Transwell Migration/Invasion Assay Method That Eases Assay Performance and Improves the Accuracy13
Repurposing Psychotropic Agents for Viral Disorders: Beyond Covid12
A Modified MTS Proliferation Assay for Suspended Cells to Avoid the Interference by Hydralazine and β-Mercaptoethanol12
Nano Spray-Dried Drugs for Oral Administration: A Review11
Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity11
Guar Gum-Based Floating Microspheres of Repaglinide Using 32 Factorial Design: Fabrication, Optimization, Characterization, and In Vivo Buoyancy Behavior in Albino Rats11
0.021366834640503